R-Biopharm AG
Humberto Giassetti has extensive work experience in various roles and industries. Humberto is currently the Director Clinical Sales International at R-Biopharm AG since 2022. Prior to that, they served as the Managing Director at Roesys MedTec GmbH from 2018 to 2022. From 2014 to 2018, they held multiple positions at Vogt Medical, including Marketing Director, Director Business Development, International Sales Manager, and Area Sales Manager. Before that, they worked at Herrenknecht Vertical GmbH as a Project Manager and Sales Engineer from 2012 to 2014. Humberto began their career at Herrenknecht AG as a Student in 2008. Throughout their career, they have demonstrated skills in sales, marketing, business development, project management, and coordination.
Humberto Giassetti's education history includes a Dipl. -Ing. in Mechanical Engineering from the Karlsruhe Institute of Technology (KIT), which they obtained from 2008 to 2011. Humberto then pursued an MBA in Business Strategy, Entrepreneurship, Marketing, Innovation & Digital Transformation from thePower from 2021 to 2022.
Prior to that, Giassetti completed a B. Eng. in Mechanical Engineering at the Karlsruhe Institute of Technology (KIT) from 2002 to 2008. In 2002, they also briefly studied Industrial Engineering at USP - Universidade de São Paulo. It is worth noting that the degree name for this particular education experience is not provided.
This person is not in any offices
R-Biopharm AG
R-Biopharm AG, located in Darmstadt, is one of Germany’s leading biotechnology companies. It considers itself as a pioneer for health and quality of life. The company´s aspiration is to provide the highest possible precision, safety, clarity and certainty with excellent products and solutions – in prevention, therapy and healing. Research and development at R-Biopharm has developed agile processes in order to take on new challenges to accompany a steadily growing world population into a new health era with sustainable solutions. As an internationally recognized leader, R-Biopharm stands for the development of excellent technologies, products and solutions in the fields of Clinical Diagnostics, Nutrition Care and Food and Feed Analytics. R-Biopharm is the global market leader for test systems in the field of allergen analysis. The biotechnology company is known for its products that are of high importance for human health. To this end, it unites development, production and sales under one roof and is successfully represented in more than 120 countries worldwide – through 28 subsidiaries and 120 distributors. Founded in 1988, the family-run company employs a total of around 1,300 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the “Sustainability Award” for sustainable and profitable growth. R-Biopharm is cultivating a value-oriented corporate culture and management and is family-run in the second generation. The Chairman of the Board of Directors is Christian Dreher.